These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 24157181)

  • 1. Why patients who die of worsening pulmonary arterial hypertension are not on parenteral prostacyclin analog treatment?
    Tonelli AR; Dweik RA
    J Heart Lung Transplant; 2014 Feb; 33(2):221. PubMed ID: 24157181
    [No Abstract]   [Full Text] [Related]  

  • 2. Cause of death in patients with pulmonary arterial hypertension.
    Farber HW; Miller DP
    J Heart Lung Transplant; 2014 Feb; 33(2):222. PubMed ID: 24365766
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of patients with pulmonary arterial hypertension at the time of death or deterioration to functional class IV: insights from the REVEAL Registry.
    Farber HW; Miller DP; Meltzer LA; McGoon MD
    J Heart Lung Transplant; 2013 Nov; 32(11):1114-22. PubMed ID: 24035189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination therapy in pulmonary arterial hypertension.
    Pugh ME; Hemnes AR; Robbins IM
    Clin Chest Med; 2013 Dec; 34(4):841-55. PubMed ID: 24267308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Current issues in pulmonary hypertension].
    Forster T
    Orv Hetil; 2012 Apr; 153(16):603-6. PubMed ID: 22510315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Has the 6-min walk distance run its course?
    McLaughlin VV
    Chest; 2012 Dec; 142(6):1363-1365. PubMed ID: 23208324
    [No Abstract]   [Full Text] [Related]  

  • 7. Gender-related differences in pulmonary arterial hypertension targeted drugs administration.
    Marra AM; Benjamin N; Eichstaedt C; Salzano A; Arcopinto M; Gargani L; D Alto M; Argiento P; Falsetti L; Di Giosia P; Isidori AM; Ferrara F; Bossone E; Cittadini A; Grünig E
    Pharmacol Res; 2016 Dec; 114():103-109. PubMed ID: 27771466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary arterial hypertension: a current review of pharmacological management.
    Sahni S; Ojrzanowski M; Majewski S; Talwar A
    Pneumonol Alergol Pol; 2016; 84(1):47-61. PubMed ID: 26693827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary arterial hypertension : a comprehensive review of pharmacological treatment.
    Berman Rosenzweig E; Barst RJ
    Treat Respir Med; 2006; 5(2):117-27. PubMed ID: 16512692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of Pulmonary Arterial Hypertension.
    Weatherald J; Varughese RA; Liu J; Humbert M
    Semin Respir Crit Care Med; 2023 Dec; 44(6):746-761. PubMed ID: 37369218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving care for patients with pulmonary hypertension: comment on "Referral of patients with pulmonary hypertension diagnoses to tertiary pulmonary hypertension centers: the multicenter RePHerral study".
    Redberg RF
    JAMA Intern Med; 2013 May; 173(10):893. PubMed ID: 23568571
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug treatment of pulmonary hypertension in children.
    Vorhies EE; Ivy DD
    Paediatr Drugs; 2014 Feb; 16(1):43-65. PubMed ID: 24114695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral treprostinil for the treatment of pulmonary arterial hypertension in patients on background endothelin receptor antagonist and/or phosphodiesterase type 5 inhibitor therapy (the FREEDOM-C study): a randomized controlled trial.
    Tapson VF; Torres F; Kermeen F; Keogh AM; Allen RP; Frantz RP; Badesch DB; Frost AE; Shapiro SM; Laliberte K; Sigman J; Arneson C; Galiè N
    Chest; 2012 Dec; 142(6):1383-1390. PubMed ID: 22628490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treating pulmonary hypertension in pediatrics.
    Lador F; Sekarski N; Beghetti M
    Expert Opin Pharmacother; 2015 Apr; 16(5):711-26. PubMed ID: 25665593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Is pulmonary hypertension diagnosed correctly and early enough? Highly relevant dilemma: incomplete diagnostic, inaccurate treatment].
    Rosenkranz S
    Dtsch Med Wochenschr; 2013 Sep; 138(37):1820. PubMed ID: 24006160
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of pulmonary arterial hypertension: the role of prostacyclin and prostaglandin analogs.
    Safdar Z
    Respir Med; 2011 Jun; 105(6):818-27. PubMed ID: 21273054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival of Japanese patients with pulmonary arterial hypertension after the introduction of endothelin receptor antagonists and/or phosphodiesterase type-5 inhibitors.
    Sakao S; Tanabe N; Kasahara Y; Tatsumi K
    Intern Med; 2012; 51(19):2721-6. PubMed ID: 23037462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [What is new in the treatment of pulmonary artery hypertension?].
    Pulido Zamudio T
    Arch Cardiol Mex; 2003; 73 Suppl 1():S121-4. PubMed ID: 12966661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral treprostinil for the treatment of pulmonary arterial hypertension in patients receiving background endothelin receptor antagonist and phosphodiesterase type 5 inhibitor therapy (the FREEDOM-C2 study): a randomized controlled trial.
    Tapson VF; Jing ZC; Xu KF; Pan L; Feldman J; Kiely DG; Kotlyar E; McSwain CS; Laliberte K; Arneson C; Rubin LJ;
    Chest; 2013 Sep; 144(3):952-958. PubMed ID: 23669822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary Arterial Hypertension-Specific Drug Therapy in COPD Patients with Severe Pulmonary Hypertension and Mild-to-Moderate Airflow Limitation.
    Calcaianu G; Canuet M; Schuller A; Enache I; Chaouat A; Kessler R
    Respiration; 2016; 91(1):9-17. PubMed ID: 26492415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.